Article

Patient attrition in Molecular Tumour Boards: A Review

2021-10-07

Abstract excerpt

Molecular Tumour Boards (MTBs) were created with the purpose of supporting clinical decision making within precision medicine. Though these meetings are in use globally reporting often focuses on the small percentages of patients that receive treatment via this process and are less likely to report on, and assess, patients who do not receive treatment. A literature review was performed to understand patient attrit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89a5a009-7c81-5597-887f-325e3caf87cf
DOI: 10.1101/2021.10.07.21264241

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Patient attrition in Molecular Tumour Boards: A ReviewDOI 10.1101/2021.10.07.21264241Read

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity Read

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.Semantic proximity Read

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.Semantic proximity Read

The molecular tumor board—a key element of precision oncologySemantic proximity Read

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer.Semantic proximity Read

Molecular Tumor Boards in Clinical Practice.Semantic proximity Read

Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non–Small-Cell Lung Cancer With Rare or Complex Mutational ProfilesSemantic proximity Read

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicineSemantic proximity Read

Molecular Tumor Board: The University of California San Diego Moores Cancer Center ExperienceSemantic proximity Read

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.Semantic proximity Read

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologySemantic proximity Read

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.Semantic proximity Read